Skip to content

Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases

Minimally Invasive(Laparoscopic and Robotic) Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03895723
Enrollment
220
Registered
2019-03-29
Start date
2019-03-01
Completion date
2024-04-01
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Liver Metastasis

Keywords

Colorectal liver metastasis, Minimally invasive surgery, Robotic surgery, Laparoscopic surgery

Brief summary

To examine survival of patients who underwent minimally invasive versus open liver resection for colorectal cancer with liver metastases.

Detailed description

the minimally invasive procedure contain laparoscopic or robotic surgery

Interventions

PROCEDURElaparoscopic and robotic liver resection

laparoscopic and robotic procedure for liver resection

PROCEDUREopen surgery

using open surgery procedure for liver resection

Sponsors

Xu jianmin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The assessor was masking for patients treatment arms

Intervention model description

Arm A: minimally invasive surgery Arm B: open

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* patients were diagnosed with colorectal cancer liver metastases * without extra-hepatic liver metastases * age were within 18-75 yeas * the numbers of metastases more than 3 * the maximal tumor size of liver metastases more than 10 cm

Exclusion criteria

* liver metastases were unresectable.

Design outcomes

Primary

MeasureTime frameDescription
disease-free survival (DFS)3 years disease-free survivalDFS was calculated from the date of liver resection to the date of death or recurrence or new tumors developing

Secondary

MeasureTime frameDescription
Overall survival (OS)5 years overall survivalOS was calculated from the date of liver resection to the date of death with any reason
Sugical complications1 months after sugeryAccording to Claivein-Dindo surgical complication system to calculate the perioperative complications related to surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026